期刊文献+

急性白血病病人骨髓细胞BAALC基因表达及意义 被引量:3

EXPRESSION AND CLINICAL SIGNIFICANCE OF BAALC GENE IN PATIENTS WITH ACUTE LEUKEMIA
下载PDF
导出
摘要 目的通过检测脑和急性白血病胞质(BAALC)mRNA在急性白血病(AL)病人表达,探讨其与AL病情进展及预后关系。方法应用逆转录聚合酶链反应技术,检测20例急性髓系白血病(AML)、8例急性淋巴细胞白血病(ALL)及11例特发性血小板减少性紫癜(ITP)、缺铁性贫血(IDA)等非恶性血液病病人(对照组)骨髓单个核细胞BAALC mRNA表达水平。结果初治组AL病人BAALC mRNA表达水平较对照组显著升高(F=8.59,q=5.62,P<0.05);经治疗获完全缓解后,与初治组比较,其表达水平显著下降,两组比较差异有显著性(q=3.99,P<0.05)。BAALC mRNA表达水平与AL病人外周血白细胞计数及骨髓原始细胞比例无明显相关性(P>0.05)。结论 BAALC mRNA表达与AL疾病进展及预后密切相关,可作为AL预后判断的有意义指标。 Objective To detect the expression of brain and acute leukemia cytoplasmic(BAALC) gene in patients with acute leukemia(AL),and explore the relationship between the expression and the outcome of AL. Methods The expression of BAALC mRNA was detected,by reverse transcription-PCR,in mononuclear cells of 20 patients with AML,eight with ALL and 11 with idiopathic thrombocytopenic purpura(ITP),iron deficiency anemia(IDA) and other non-malignant hematological diseases. Results In newly diagnosed patients with AL,the expression of BAALC mRNA was obviously higher than that in the normal controls(F=8.59,q=5.62,P〈0.05).When the patients achieved complete remission,the expression of BAALC mRNA was markedly lower than that of the newly diagnosed group,the difference was statistically significant(q=3.99,P〈0.05).The expression of BAALC mRNA in patients with AL was not correlated with peripheral blood cell counts and the proportion of bone marrow blast cells. Conclusion The expression of BAALC mRNA is closely associated with the progression and prognosis of AL,which can be used as a significant parameter to predict the prognosis of AL.
出处 《齐鲁医学杂志》 2012年第2期112-114,共3页 Medical Journal of Qilu
关键词 急性白血病 脑和急性白血病胞质基因 逆转录聚合酶链反应 acute leukemia brain and acute leukemia cytoplasmic gene reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献6

  • 1STEPHAN M T,AUSTION,GUSTAVO L,et al.BAALC,the member of a novel mammalian neuroectoderm gene line-age,is implicated in hematopoiesis and acute leukemia[J].PNAS,2001,98(24):13901-13906.
  • 2CLAUDIA D B,STEPHAN M T,DONNA F K,et al.BAALC,a novel marker of human hematopoietic progenitorcells[J].Experimental Hematology,2003,31:1051-1056.
  • 3李红艺,魏旭东,吕晓东,岳寒,范瑞华,徐本玲,郭金东,胡杰英,房佰俊,宋永平.实时荧光定量PCR检测BAALC基因在正常核型急性髓系白血病中的表达[J].中国现代医学杂志,2008,18(12):1706-1709. 被引量:6
  • 4CLAUDIA D B,STEPHAN M T,AMY S R,et al.BAALCexpression predicts clinical outcome of de novo acute myeloidleukemia patients with normal cytogenetics:a cancer and leu-kemia group B study[J].Blood,2003,102:1613-1618.
  • 5CARLOS S,MARIA C C,RAMON G S,et al.BAALC is animportant predictor of refractoriness to chemotherapy and poorsurvival in intermediate-risk acute myeloid leukemia(AML)[J].Ann Hematol,2010,89:453-458.
  • 6孟繁军,罗兵,曲彦,李广伦,宋玉华.急性白血病多药耐药相关蛋白基因表达及临床意义[J].青岛大学医学院学报,2000,36(4):253-255. 被引量:1

二级参考文献21

  • 1杨仁池,杨纯正,郝玉书,熊冬生,邵晓枫,许元富,陈桂彬,卞寿庚.急性白血病多药耐药相关蛋白基因表达及其与免疫表型和FAB分型的关系[J].中华血液学杂志,1996,17(7):339-341. 被引量:9
  • 2Nooter K,Sonneveld P.Clinical relevance of P-glycoprotein expression in haematological malignancies[J].Leuk Res,1994,18:233
  • 3Cole SPC,Bhard WG,Gerlach JH, et al.Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line[J].Science,1992,258:1650
  • 4Chomcyzynski P,Sacchi N.Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction[J].Anal Biochem,1987,162:156
  • 5Hiddemann W,Buchner T.Treatment strategies in acute myeloid leukemia (AML)[J].blut,1990,60:163
  • 6Burger H,Nooter K,Zaman GJR, et al.Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukaemias[J].Leukemia,1994,8:990
  • 7Hart SM,Ganeshanggurn K,Hoffbrand AV,et al.Expression of the multidrug resistance-associated protein (MRP) in acute Leukaemias[J].Leukemia,1994;8:2163
  • 8TANNER SM, AUSTIN JL, LEONE G, et al. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia [J]. Proc Natl Acad Sci USA, 2001, 98: 13901-13906.
  • 9BACHER U, HAFERLACH T, SCHOCH C. Implications of NRAS mutations in AML: a study of 2502 patients [J]. Blood, 2006, 107: 3847-3853.
  • 10BIENZ M, LUDWIG M, OPPLIGER LEIBUNDGUT E, et al. Risk assessment in patients with acute myeloid leukemia and a normal karyotype [erratum appears in Clin Cancer Res. 2005; 11: 5659][J]. Clin Cancer Res, 2005, 11: 1416-1424.

共引文献5

同被引文献28

  • 1唐雪娟,任莉.低剂量沙利度胺联合常规化疗治疗多发性骨髓瘤的临床分析[J].中国生化药物杂志,2014,34(4):113-115. 被引量:21
  • 2应逸,陈建兰,王汉平,谢健晋,周薇,陈小卫,陈小燕.急性髓细胞白血病NPM1和FLT3-ITD突变检测临床意义分析[J].中华肿瘤防治杂志,2013,20(2):121-124. 被引量:6
  • 3徐兵,宋小燕,唐家宏,周淑芸,胡斌.荧光定量PCR检测急性髓细胞白血病患者BAALC基因及临床意义[J].中华检验医学杂志,2007,30(10):1123-1126. 被引量:10
  • 4THIEDE C, KOCH S, CREUTZIG E, et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) [J]. Blood, 2006, 107 (10) :4011-4020.
  • 5PARK G, CHI H S, PARK S J, et al. Clinical implications of non-A-type NPM1 and FLT3 mutations in patients with nor-mal karyotype acute myeloid leukemia[J]. Acta Haematologi- ca, 2012,127(2):63-71.
  • 6FALINI B, MECUCCI C, TIACCI E, et al. Cytoplasmic nu- cleophosmin in acute myelogenous leukemia with a normal karyotype[J]. New England Journal of Medicine, 2005,352 (3) :254-266. .
  • 7DOHNER K, DOHNER H. Molecular characterization of acute myeloid leukemia[J]. Haematologiea, 2008,93 (7) .. 976- 982.
  • 8CHAUHAN P S, BHUSHAN B, MISHRA A K, et al. Muta- tion of FLT3 gene in acute myeloid leukemia with normal cyto- genetics and its association with clinical and immunophenotypic features[J]. Medical Oncology, 2011,28(2) ..544-551.
  • 9THIEDE C, STEUDEL C, MOHR B, et al. Analysis of FLT3-activating mutations in 979 patiem, with acute myeloge- nous leukemia: association with FAB subtypesand identifica- tion of subgroups with poor prognosis[J]. Blood, 2002, 99 (12) ;4326-4335.
  • 10SCHLENK R F, DHNER K, KRAUTER J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid Ieukemia[J']. New England Journal of Medicine, 2008, 358 (18) : 1909-1918.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部